Corcept Therapeutics Stock Drops After Losing Patent Appeal to Teva
Corcept Therapeutics shares fell sharply to $29.71 in morning trading, following a Federal Circuit ruling affirming no patent infringement by Teva's generic version of Korlym.
NOTRELOAD AI
Traws Pharma Falls After FDA Puts Flu Drug Application on Clinical Hold
Traws Pharma stock dropped 23% today after the FDA placed a clinical hold on its monthly flu prevention pill due to mutagenicity concerns. Positive COVID drug results couldn’t offset the news.
Raymond James Turns Bullish on Chewy: “Attractive” After 33% Drop
Raymond James upgrades Chewy stock to Outperform with a $28 target, calling the 33% drop since Q3 an attractive risk/reward setup thanks to low expectations and strong 2026 growth potential.
Kinetik Holdings Eyes Potential Sale Amid US Natural Gas Boom
Kinetik Holdings, a major pipeline operator in the Delaware Basin, is exploring a sale after interest from Occidental-backed Western Midstream. This comes as surging natural gas demand fuels more energy deals.
Klarna Hits $1B Revenue Record in Q4 2025 – But Swings to $26M Loss
Klarna smashed its first-ever billion-dollar quarter with 38% revenue growth and huge US & banking gains. Despite the $26M net loss, the company is rapidly turning payments users into full banking customers.
Wayfair Stock Drops After Mixed Q4 2025 Earnings
Wayfair beat revenue and adjusted profit forecasts but missed on reported losses due to debt costs — shares fell in premarket despite strong customer growth.